Nunzia Pharmaceutical Stock Probability of Future Pink Sheet Price Finishing Under 0.003

NUNZ Stock  USD 0  0.00  0.00%   
Nunzia Pharmaceutical's future price is the expected price of Nunzia Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Nunzia Pharmaceutical performance during a given time horizon utilizing its historical volatility. Check out Nunzia Pharmaceutical Backtesting, Nunzia Pharmaceutical Valuation, Nunzia Pharmaceutical Correlation, Nunzia Pharmaceutical Hype Analysis, Nunzia Pharmaceutical Volatility, Nunzia Pharmaceutical History as well as Nunzia Pharmaceutical Performance.
  
Please specify Nunzia Pharmaceutical's target price for which you would like Nunzia Pharmaceutical odds to be computed.

Nunzia Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nunzia Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nunzia Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Nunzia Pharmaceutical generated a negative expected return over the last 90 days
Nunzia Pharmaceutical has some characteristics of a very speculative penny stock
Nunzia Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
Nunzia Pharmaceutical currently holds 139.96 K in liabilities. Nunzia Pharmaceutical has a current ratio of 0.2, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nunzia Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Nunzia Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nunzia Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nunzia to invest in growth at high rates of return. When we think about Nunzia Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (9.02 M) with profit before overhead, payroll, taxes, and interest of 0.
Nunzia Pharmaceutical currently holds about 5.07 K in cash with (86.78 K) of positive cash flow from operations.
Roughly 82.0% of the company outstanding shares are owned by corporate insiders

Nunzia Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nunzia Pink Sheet often depends not only on the future outlook of the current and potential Nunzia Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nunzia Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding284.9 M
Cash And Short Term Investments131.00

Nunzia Pharmaceutical Technical Analysis

Nunzia Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Nunzia Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nunzia Pharmaceutical. In general, you should focus on analyzing Nunzia Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Nunzia Pharmaceutical Predictive Forecast Models

Nunzia Pharmaceutical's time-series forecasting models is one of many Nunzia Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nunzia Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Nunzia Pharmaceutical

Checking the ongoing alerts about Nunzia Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nunzia Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Nunzia Pharmaceutical generated a negative expected return over the last 90 days
Nunzia Pharmaceutical has some characteristics of a very speculative penny stock
Nunzia Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
Nunzia Pharmaceutical currently holds 139.96 K in liabilities. Nunzia Pharmaceutical has a current ratio of 0.2, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nunzia Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Nunzia Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nunzia Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nunzia to invest in growth at high rates of return. When we think about Nunzia Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (9.02 M) with profit before overhead, payroll, taxes, and interest of 0.
Nunzia Pharmaceutical currently holds about 5.07 K in cash with (86.78 K) of positive cash flow from operations.
Roughly 82.0% of the company outstanding shares are owned by corporate insiders

Additional Tools for Nunzia Pink Sheet Analysis

When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.